Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Receives Average Rating of Moderate Buy from Brokerages modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
StockNews.com downgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Rating) from a buy rating to a hold rating in a report issued on Friday. CPRX has been the topic of several other reports. Truist Financial lifted their price objective on Catalyst Pharmaceuticals from $22.00 to $24.00 in a research note on Tuesday, June 20th. Cantor […]
StockNews.com upgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Rating) from a hold rating to a buy rating in a report published on Thursday. Separately, Cantor Fitzgerald boosted their price objective on Catalyst Pharmaceuticals from $22.00 to $25.00 in a research note on Friday, March 17th. One investment analyst has rated the stock with a […]
Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) dropped 2.7% on Tuesday . The company traded as low as $11.52 and last traded at $11.58. Approximately 873,405 shares were traded during trading, a decline of 59% from the average daily volume of 2,113,459 shares. The stock had previously closed at $11.90. Analysts Set New […]
StockNews.com cut shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Rating) from a strong-buy rating to a buy rating in a research note published on Tuesday morning. A number of other research firms have also recently commented on CPRX. Cantor Fitzgerald upped their target price on Catalyst Pharmaceuticals from $22.00 to $25.00 in a research note […]